Our dedicated oncology team is comprised of oncology-trained clinical trial specialists across all functional areas. We recognize hematologic malignancies are distinct from solid tumors, and have built specific hematologic oncology teams and processes to support these studies. Our specialists understand the clinical implications of blood-based cancers, the diverse pathologies, complex assessments, sick patient population, and lab-based endpoints inherent in hematologic trials. 

Download this fact sheet to learn more about our hematologic oncology expertise.